Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Kidney Transplantation
Interventions
DRUG

GI medication

Patients on daily dosing were asked to discontinue their GI medication at baseline. Patients on twice daily dosing were asked to reduce GI medication to once a day at baseline and asked to discontinue GI medication at day 30.

Trial Locations (1)

27834

Brody School of Medicine at East Carolina University, Greenville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

East Carolina University

OTHER

NCT00905242 - Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients | Biotech Hunter | Biotech Hunter